Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan.
Hepatol Int
; 15(2): 338-349, 2021 Apr.
Article
in En
| MEDLINE
| ID: mdl-33677787
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hepatitis C, Chronic
Type of study:
Guideline
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Hepatol Int
Year:
2021
Document type:
Article